SPINOCEREBELLAR ATAXIA
Clinical trials for SPINOCEREBELLAR ATAXIA explained in plain language.
Never miss a new study
Get alerted when new SPINOCEREBELLAR ATAXIA trials appear
Sign up with your email to follow new studies for SPINOCEREBELLAR ATAXIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a drug slow rare brain disease? new study uses Real-World data to find out
Disease control OngoingThis study looks at whether the drug troriluzole can slow the progression of spinocerebellar ataxia (SCA), a rare genetic disease that affects movement and balance. Researchers will compare 909 patients who took troriluzole for up to three years with similar patients who did not …
Matched conditions: SPINOCEREBELLAR ATAXIA
Sponsor: Biohaven Therapeutics Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Smartphone app could reveal how exercise helps the brain in rare movement disorder
Knowledge-focused TerminatedThis study was designed to see if a smartphone app called iBlink can measure how well the brain learns new movements in people with spinocerebellar ataxia, a rare and serious movement disorder. Researchers planned to compare aerobic exercise with balance training to see which bet…
Matched conditions: SPINOCEREBELLAR ATAXIA
Phase: NA • Sponsor: Columbia University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Body-Worn sensors could revolutionize ataxia tracking
Knowledge-focused OngoingThis study uses small body-worn sensors to measure movement during simple coordination tests in people with spinocerebellar ataxia, a condition that affects balance and walking. Researchers aim to see if these sensors can accurately track disease severity and progression. The stu…
Matched conditions: SPINOCEREBELLAR ATAXIA
Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC